Plasma‐derived product recipients' views on the acceptability of implementing a programme of plasma donation for fractionation from men who have sex with men

Author:

Benoit Justine1,Caruso Jessica1,Germain Marc2,Myhal Geneviève3,Monteith Ken4,Otis Joanne1ORCID

Affiliation:

1. Département de sexologie Université du Québec à Montréal Québec Canada

2. Medical Affairs and Innovation Héma‐Québec Québec Canada

3. Business Intelligence and Marketing Research Héma‐Québec Québec Canada

4. COCQ‐SIDA Québec Canada

Abstract

AbstractBackground and ObjectivesOver the past few years in Québec, Canada, exclusion criteria for blood donation and plasma donation for fractionation have been modified. Héma‐Québec, the institution responsible for blood products, has made changes to allow more inclusive access to blood and plasma donation, in accordance with evolving scientific data concerning donation safety. The study, conducted before those changes were implemented, aimed to assess acceptability of recipients and parents of recipients of plasma‐derived products for men who have sex with men (MSM) to become eligible to donate plasma for fractionation.Materials and MethodsEight qualitative interviews (4 focus groups, 4 individual) were conducted with a total of 17 plasma product recipients and parents of children needing plasma‐derived products. Data were analysed using thematic analysis.ResultsParticipants were rather favourable regarding acceptability of MSM as potential donors. Participants viewed this change as necessary and beneficial. They also felt they must rely on trust in Héma‐Québec, conferred automatically or by default. However, some participants raised concerns about donation safety and reported feeling helpless regarding inclusion of MSM. The importance of being informed and that recipients' safety be prioritized first and foremost were also mentioned.ConclusionDespite their nuanced attitudes, recipients showed high levels of acceptability of including MSM in plasma donation for fractionation. Actions can be taken to reduce concerns regarding the safety of products received.

Funder

Canadian Blood Services

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3